Article Figures & Data
Tables
- Table 1
- Demographics, family history, and pregnancy details of patients with perinatal stroke (N=32).
Characteristics N (%) Males 15 (46.9) Females 17 (53.1) Maternal history Hypothyroidism 6 (18.75) Recurrent abortions 5 (15.63) Myasthenia gravis 1 (3.13) COVID-19 infection 1 (3.13) Epilepsy 1 (3.13) Normal 23 (71.88) Family history Seizures 7 (21.88) Stroke 1 (3.13) Haematological diseases 1 (3.13) Congenital heart diseases 0 (0) Renal diseases 0 (0) Metabolic diseases 0 (0) Immunological diseases 0 (0) Liver/GI diseases 0 (0) Consanguinity Consanguineous parents 20 (62.5) Pregnancy Normal 28 (87.5) Abnormal 4 (12.5) Full term 29 (90.62) Preterm 3 (9.37) COVID-19, coronavirus disease 2019; GI, gastrointestinal
First stroke symptoms: N (%) Hemiparesis 18 (56.25) Seizures 12 (37.5) Respiratory distress 1 (3.13) Tiptoe walking 1 (3.13) Age at stroke diagnosis At birth 6 (18.75) 1–12 months 4 (12.5) 13–16 months 5 (15.62) 17-23 months 0 (0) 2–3 years 8 (25) 4–5 years 3 (6.25) Unknown 6 (18.75) Assessment N (%) MRA abnormality MRA scan 8 (25) MRI/CT scan Left MCA 13 (40.63) Right MCA 4 (12.5) Others 15 (46.88) MRA, magnetic resonance angiography; MRI, magnetic resonance imaging; CT, computed tomography; MCA, middle cerebral artery
- Table 4
- Diagnosis of epilepsy, age at seizure onset, and assessment of seizure control in patients with perinatal stroke (N=32).
Diagnosis N (%) Epilepsy 22 (68.75) Age at onset of seizures Birth 4 (18.18) 1–6 months 7 (31.81) 7 months to 2 years 6 (27.27) 3–10 years 5 (22.72) Seizures assessment Seizure-free (ASMs discontinued) 5 (22.72) Controlled seizures (receiving ASMs) 11 (50) Partially controlled seizures 3 (13.63) Uncontrolled seizures 2 (9.09) Unknown 1 (3.13) ASMs - anti-seizure medications
IQ assessment N (%) High average (110–119) 1 (3.13) Average (90–109) 3 (9.37) Low average (80–89) 1 (3.13) Borderline impairment (70–79) 5 (15.63) Moderately impaired (40–54) 1 (3.13) Severely impaired (<40) 1 (3.13) IQ - intelligence quotient